igf-1 lr3 + follistatin Rc Insulin growth factor(IGF1-LR3) Stacking IGF-1 LR3 Follistatin-344 Muscle

Cerebrolysin Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse Cerebrolysin doses depending on species, condition, and route: Preclinical Studies: Rat stroke models: 2.5-7.5 ml/kg optimal range (0.8-7.5 ml/kg studied) Rat TBI models: 2.5 ml/kg identified as optimal dose Mouse neurodegenerative models: 5 ml/kg typical dose Administration timing: Usually 4 hours post-injury, daily for 10-21 days Human Clinical Trials: Acute stroke: 30-50 ml/day intravenously for 10-21 days Vascular dementia: 20-30 ml/day for 4-week cycles Alzheimers disease: 10-60 ml/day for 4-24 weeks Traumatic brain injury: 30-50 ml/day for 10-21 days Important: These dosing regimens are specific to the conditions and species studied and cannot be extrapolated across species or indications due to significant differences in pharmacokinetics, peptide metabolism, receptor expression patterns, and disease pathophysiology

G.et al (2004)

*Turmeric which is said to lighten dark spots by inhibiting melanin production

When you combine a high-quality, bioavailable supplement with these lifestyle choices, you create a foundation for long-term health

Nat Methods 5 , 553559 (2008)

References: